Back
NovaBay Pharmaceuticals Stock Price Chart
Sponsored
NBY
Sponsored
Elon's Secret "A.I. 2.0" Project
Click here now to discover how to claim a stake in Elon's "A.I. 2.0" project
Sell
7
NBY
NovaBay Pharmaceuticals
Last Price:
0.08
Seasonality Move:
-9.04%
7 Day Trial
ALL ACCESS PASS
$
7
He cracked the code to crypto
Now he says a new two-year bull market has begun. And he likes one altcoin above all others.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
NovaBay Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.09 | Sell |
20-day SMA: | 0.11 | Sell |
50-day SMA: | 0.13 | Sell |
200-day SMA: | 0.36 | Sell |
8-day EMA: | 0.09 | Sell |
20-day EMA: | 0.1 | Sell |
50-day EMA: | 0.13 | Sell |
200-day EMA: | 0.61 | Sell |
NovaBay Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 23.8 | Sell |
Chaikin Money Flow: | 1016959 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.09 - 0.13) | Sell |
Bollinger Bands (100): | (0.12 - 0.24) | Sell |
NovaBay Pharmaceuticals Technical Analysis
Apr 3 | Apr 4 | Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for NovaBay Pharmaceuticals Stock
Is NovaBay Pharmaceuticals Stock a Buy?
- NovaBay Pharmaceuticals share price is 0.08 while NBY 8-day simple moving average is 0.09, which is a Sell signal.
- The stock price of NBY is 0.08 while NovaBay Pharmaceuticals 20-day SMA is 0.11, which makes it a Sell.
- NovaBay Pharmaceuticals 50-day simple moving average is 0.13 while NBY share price is 0.08, making it a Sell technically.
- NBY stock price is 0.08 and NovaBay Pharmaceuticals 200-day simple moving average is 0.36, creating a Sell signal.
NBY Technical Analysis vs Fundamental Analysis
Sell
7
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy or a Sell?
-
NovaBay Pharmaceuticals stock is rated a Sell
The current NovaBay Pharmaceuticals [NBY] share price is $0.08. The Score for NBY is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
NovaBay Pharmaceuticals Stock Info
Market Cap:
2.39M
Price in USD:
0.08
Share Volume:
1.83M
NovaBay Pharmaceuticals 52-Week Range
52-Week High:
1.95
52-Week Low:
0.07
Sell
7
NovaBay Pharmaceuticals (NBY)
is a Sell
NovaBay Pharmaceuticals Share Price Forecast
-
What is the NovaBay Pharmaceuticals stock price today?
The NovaBay Pharmaceuticals stock price is 0.08 USD today. -
Will NBY stock go up or go down?
NovaBay Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is NovaBay Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, NovaBay Pharmaceuticals is overvalued.
Is NovaBay Pharmaceuticals Stock a Buy?
- NovaBay Pharmaceuticals share price is 0.08 while NBY 8-day exponential moving average is 0.09, which is a Sell signal.
- The stock price of NBY is 0.08 while NovaBay Pharmaceuticals 20-day EMA is 0.10, which makes it a Sell.
- NovaBay Pharmaceuticals 50-day exponential moving average is 0.13 while NBY share price is 0.08, making it a Sell technically.
- NBY stock price is 0.08 and NovaBay Pharmaceuticals 200-day simple moving average is 0.61, creating a Sell signal.
Fundamental Analysis of NovaBay Pharmaceuticals
Is NovaBay Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.04 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.
Technical Analysis of NovaBay Pharmaceuticals
Should I short NovaBay Pharmaceuticals stock?
- NBY Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting NovaBay Pharmaceuticals is a Sell
- NovaBay Pharmaceuticals Relative Strength Index (RSI) is 23.8, which suggest NovaBay Pharmaceuticals is oversold
- The Bollinger Bands (25) for NovaBay Pharmaceuticals is (0.09 - 0.13), which suggest NovaBay Pharmaceuticals is a Sell
- The Bollinger Bands (100) for NovaBay Pharmaceuticals is (0.12 - 0.24), which suggest NovaBay Pharmaceuticals is a Sell
* NovaBay Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.